Fig. 5From: Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007Tumor-to-organ ratios for EuE-k-18F-FBOA and EuE-k-β-a-18F-FPyl in comparison to 18F-DCFPyl and 18F-PSMA-1007 in LNCaP-tumor-bearing SCID mice at 1 and 2 h p.iBack to article page